Iladatuzumab (MCDS0593A) is a monoclonal antibody targeting CD79B and is a naked antibody to the ADC compound Iladatuzumab vedotin, which has potential anticancer activity for the study of B-cell non-Hodgkins lymphoma (B-NHL).
Reinheit:
98.70%
CAS Nummer:
[1906205-76-2]
Target-Kategorie:
ADC Antibody|||Immunology/Inflammation related
T82078
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten